Medication info
Dapljin 10 mg (Dapagliflozin Propanediol Hydrate)

Dapljin 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Dongkook Pharmaceutical Co., Ltd.
Appearance
Yellow, double-sided convex diamond-shaped film-coated tablet
Packaging
30 tablets/bottle, 90 tablets/bottle
Approval status
Active

MFDS item code 202204313 · Approved 2022.11.30 · Insurance code 653405260

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for both monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Dongkook Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control abnormalities
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. It may be used alone or in combination with other medications. In particular, caution is needed for patients with cardiovascular disease or risk factors who do not achieve adequate blood sugar control. This medication effectively aids in diabetes treatment and improves blood sugar control.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for both monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, patients allergic to the active ingredient or excipients, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients with lactose intolerance should not use this medication. Additionally, patients undergoing dialysis should also not take this medication. Patients with reduced fluid volume or renal dysfunction should use this medication with caution. This medication can lower blood pressure or reduce blood volume, which could lead to symptomatic hypotension or acute kidney injury. Especially in patients with impaired renal function, the elderly, and patients taking diuretics, fluid status and renal function should be closely evaluated before administration, and symptoms of hypotension and renal function should be continuously monitored during treatment. The most common side effect during the use of this medication is genital infection. Other reported side effects include urinary tract infections, hypoglycemia, reduced fluid volume, dizziness, dry mouth, dysuria, polyuria, hypotension, and others. Particularly, hypoglycemia may occur more frequently when used in combination with drugs such as insulin or sulfonylureas, hence caution is necessary. This medication should be used with caution in patients with poor liver function, and elderly patients should also be more closely monitored for fluid volume reduction or changes in renal function. Moreover, as this medication may cause glucose to be detected in urine tests, this should be taken into account. The risk of hypoglycemia may increase when used with insulin secretagogues, so adjustment of insulin or sulfonylurea dosing may be necessary. Use of this medication is not recommended during pregnancy, and administration should be stopped immediately if pregnancy is confirmed. Lactating women are also advised not to take this medication. In the case of overdose, there are no specific antidotes, so appropriate treatment based on clinical symptoms should be administered, and removal of this medication through dialysis has not been studied. This medication does not significantly affect the ability to drive or operate machinery; however, the risk of hypoglycemia should be acknowledged when taken with insulin or sulfonylureas. Finally, this medication should be stored out of reach of children and kept in its original container for safety.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decrease in fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, reduced creatinine clearance in the early stages of treatment, dyslipidemia, elevated serum creatinine in the early stages of treatment, increased blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic response, sensory abnormalities, cerebral infarction, nerve compression, sensory loss, headache, palpitations, insomnia, tinnitus, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased blood lactate, lymphocytopenia, decreased appetite, subsequent syndrome, taste abnormalities, nasopharyngitis, upper respiratory tract infections, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, vaginal discharge, menstrual irregularities, pruritus, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, fatty liver, gallbladder polyp, dry eye, ocular pain, retinal disorders, visual impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, ocular hypertension, visual disability, vitreous floaters

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may degrade due to air or moisture, so it should be stored in a tightly sealed container. Furthermore, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance and packaging

Appearance

Yellow, double-sided convex diamond-shaped film-coated tablet

Package unit

30 tablets/bottle, 90 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.